About ACS dobfar
ACS dobfar is a Healthcare company based in Tribiano (Italy) founded in 1973. APIs and finished dosage formulations are manufactured by ACS Dobfar. ACS dobfar offers products and services including Active Pharmaceutical Ingredients, Finished Dosage Forms, and Packaging. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides. Its legal entity is ACS DOBFAR S.p.A.
Company details
ACS dobfar is a fully integrated manufacturer of APIs as well as Finished Dosage Formulations. Products include cephalosporins, penicillins, Carbapenems and other beta-lactam anti-infectives in API category. Finished dosage form categories include dry powder vials, single and multi dose bags, infusion bags, capsules, non-coated tablets, coated tablets, MR tablets and oral suspensions. Services offered in both categories include generic sales to third parties, custom pharma services for innovators and contract manufacturing. It has about 8 API manufacturing and 4 finished dosage form manufacturing facilities.
- Headquarters Tribiano, Italy
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website acsdobfar.it
- Social LinkedIn
- Legal Name Acs Dobfar S.P.A.
- Latest Funding Round$195.06M (USD), Debt – Conventional
Sep 2016
- InvestorsNatixis
& 1 more
Products & Services of ACS dobfar
ACS dobfar offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients, Finished Dosage Forms, and Packaging.
Production of key chemical components for drugs
Development of final pharmaceutical products
Provision of packaging solutions for pharmaceuticals
Funding Insights of ACS dobfar
- Total Rounds 1
- Last Round Debt – Conventional — $195.06M
- First Round $195.06M
(Sep 2016)
- Investors Count 2
All 1 funding rounds of ACS dobfar with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in ACS dobfar
ACS dobfar has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Natixis and UniCredit.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multi-disciplinary global financial services provider | 2006 | natixis.com | Paris, France | |
Commercial bank | 1998 | unicreditgroup.eu | Milan, Italy |
Investor details for ACS dobfar
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of ACS dobfar
2 dated milestones of ACS dobfar across 43 years, from founding to its latest funding, stage changes and deals.
- Founded ACS dobfar is founded.
- Funding First funding round of $195.1M.
Web traffic of ACS dobfar
The website of ACS dobfar (acsdobfar.it) receives about 2.6K visits a month and ranks #5,123,276 among all websites worldwide, #5,877 in Biotechnology and Pharmaceuticals.
- Monthly visits2.6K
▼ 5.1% vs previous month
- Unique visitors1.1K
per month
- Global rank#5,123,276
among all websites
- Category rank#5,877
Health · Biotechnology and Pharmaceuticals
- Bounce rate31%
- Pages per visit2.7
- Average visit2 min 36 sec
- DevicesDesktop 55% · Mobile 45%
Websites whose visitors overlap most with ACS dobfar. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
idifarmaceutici.com | idifarmaceutici.com | 100% | #4,765,613 | – | |
abbvie.it | abbvie.it | 95% | #2,373,637 | – | |
| amidrugs.com | 82% | View details | |||
| bms.com | 43% | 809.8K | #67,210 | View details | |
| lilly.com | 43% | 4.9M | #13,252 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 12 similar websites and full traffic analytics for ACS dobfar
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Acs Dobfar
Complete news archive for ACS dobfar
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ACS dobfar
ACS dobfar was founded in 1973 and raised its 1st funding round 43 years after it was founded.
ACS dobfar is headquartered in Tribiano, Italy. It is registered at Tribiano, Lombardy, Italy.
ACS dobfar is a fully integrated manufacturer of APIs as well as Finished Dosage Formulations. Products include cephalosporins, penicillins, Carbapenems and other beta-lactam anti-infectives in API category. Finished dosage form categories include dry powder vials, single and multi dose bags, infusion bags, capsules, non-coated tablets, coated tablets, MR tablets and oral suspensions. Services offered in both categories include generic sales to third parties, custom pharma services for innovators and contract manufacturing. It has about 8 API manufacturing and 4 finished dosage form manufacturing facilities.
ACS dobfar offers Active Pharmaceutical Ingredients, Finished Dosage Forms, and Packaging.
ACS dobfar operates through Acs Dobfar S.P.A..